Astellas to Establish a New Manufacturing Facility for API of Prograf in Toyama Technology Center

Shots:

• Astellas will construct the Third Fermentation Building as the manufacturing facility for API of Prograf (tacrolimus hydrate) in the Toyama Technology Center of Astellas Pharma
• The establishment of the new facility will enhance Astellas’ production capacity, enabling the stable supply of Prograf in future
• The total construction cost of the facility will be ~$90M with three above-ground floors having a total floor area of ~ 7,220 m². The construction is expected to be initiated in Apr’20 with its anticipated completion in Aug’21

Click here ­to­ read full press release/ article | Ref: Astellas  | Image: Global Pharma Update